KR970009812A - 활성화 면역글로불린 - Google Patents

활성화 면역글로불린 Download PDF

Info

Publication number
KR970009812A
KR970009812A KR1019960033064A KR19960033064A KR970009812A KR 970009812 A KR970009812 A KR 970009812A KR 1019960033064 A KR1019960033064 A KR 1019960033064A KR 19960033064 A KR19960033064 A KR 19960033064A KR 970009812 A KR970009812 A KR 970009812A
Authority
KR
South Korea
Prior art keywords
immunoglobulin
activated
useful
diseases
agent
Prior art date
Application number
KR1019960033064A
Other languages
English (en)
Other versions
KR100436811B1 (ko
Inventor
김미경
하루오 요시이
미쯔루 나이키
유리꼬 후카타
Original Assignee
김미경
코니시 진우에몬
닛폰조키세야쿠 카부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김미경, 코니시 진우에몬, 닛폰조키세야쿠 카부시키가이샤 filed Critical 김미경
Publication of KR970009812A publication Critical patent/KR970009812A/ko
Application granted granted Critical
Publication of KR100436811B1 publication Critical patent/KR100436811B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Abstract

호산구증다억제제, 면역조정제, 자기면역질환치료제, 항염증제, 항알레르기제로서 유용한 활성화 면역글로불린을 제공한다.
본 발명은 천연형의 면역글로불린이 본래 나타내지 않은 새로운 약리활성을 면역글로불린에 부여하는 방법, 그 방법에 의해 얻어지는 활성화 면역글로불린 및 그 활성화 면역글로불린을 유효성분으로 함유하는 의약조성물에 관한 것이다.
본 발명의 활성화 면역글로불린은 종래의 면역억제제와는 확실히 다른 면역조정작용을 보유하여 만성관절류마티스, 전신성에리스마트데스, 다발성경화증 등의 자기면역질환이든지 각종 면역부전증후군 등의 면역계가 매우 빠진 질환에 대한 치료제로서 유용하다. 또한 본 발명의 활성화 면역글로불린은, 감염증, 기생충질환, 호흡기질환, 자기면역질환, 악성종양 등에 따른 호산구과다증에 대한 약제로서, 또한 우수한 항염증제나 항알레르기제로서도 이용할 수 있어 매우 유용성이 높다.

Description

활성화 면역글로불린
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 활성화 면역글로불린.
  2. 제 1항에 있어서, 호산구증다억제작용, 면역조정작용, 자기면역질환 개선작용, 항염증작용 또는 항알레르기작용을 보유하는 활성화 면역글로불린.
  3. 제 1항에 있어서, 면역글로불린을 히스타민성분과 혼합처리한 후에 히스타민을 제거하는 활성화조직에 의해 얻어진 활성화 면역글로불린.
  4. 제 1항 기재의 활성화 면역글로불린을 함유하는 의약.
  5. 제 4항에 있어서, 호산구증다억제제인 것을 특징으로 하는 의약.
  6. 제 4항에 있어서, 면역조정제인 것을 특징으로 하는 의약.
  7. 제 4항에 있어서, 자기면역질환치료제인 것을 특징으로 하는 의약.
  8. 제 4항에 있어서, 항염증제인 것을 특징으로 하는 의약.
  9. 제 4항에 있어서, 항알레르기제인 것을 특징으로 하는 의약.
  10. 제 4항에 있어서, 주사제인 것을 특징으로 하는 의약.
  11. 제 4항에 있어서, 경구제인 것을 특징으로 하는 의약.
  12. 면역글로불린을 히스타민성분과 혼합처리한 후에 히스타민을 제거하는 면역글로불린의 활성화방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960033064A 1995-08-11 1996-08-08 활성화면역글로불린 KR100436811B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7227045A JPH0959180A (ja) 1995-08-11 1995-08-11 活性化免疫グロブリン
JP95-227045 1995-08-11

Publications (2)

Publication Number Publication Date
KR970009812A true KR970009812A (ko) 1997-03-27
KR100436811B1 KR100436811B1 (ko) 2004-08-25

Family

ID=16854669

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960033064A KR100436811B1 (ko) 1995-08-11 1996-08-08 활성화면역글로불린

Country Status (10)

Country Link
US (1) US6627194B1 (ko)
EP (1) EP0758656B1 (ko)
JP (1) JPH0959180A (ko)
KR (1) KR100436811B1 (ko)
CN (1) CN1108818C (ko)
AT (1) ATE252603T1 (ko)
AU (1) AU713296B2 (ko)
CA (1) CA2183020A1 (ko)
DE (1) DE69630423T2 (ko)
TW (1) TW442495B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10212246A (ja) 1997-01-30 1998-08-11 Nippon Zoki Pharmaceut Co Ltd 経口投与用製剤
CA2232420A1 (en) * 1997-03-19 1998-09-19 The Green Cross Corporation Immunoglobulin preparation and preparation process thereof
JP2000143536A (ja) 1998-11-13 2000-05-23 Nippon Zoki Pharmaceut Co Ltd 抗浮腫剤
DE19944122A1 (de) * 1999-09-15 2001-03-29 Wolfgang Loh Histamin-Immunglobulin-Komplexe zur Behandlung von entzündlichen Erkrankungen bei Säugetieren
KR20070108320A (ko) * 2006-03-20 2007-11-09 전숙영 알레르기질환 및 자가면역질환의 치료를 위한 약학적조성물, 그의 용도 및 알레르기질환 및 자가면역질환의치료방법
RU2505312C2 (ru) * 2010-08-06 2014-01-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения гриппа различных типов
RU2502521C2 (ru) * 2010-08-06 2013-12-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций
CN110801013B (zh) * 2019-11-19 2023-03-31 西北农林科技大学 一种生物化学法制备非过敏生漆或漆酚的方法及其产品

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873697A (en) 1972-11-11 1975-03-25 Mack Chem Pharm Histamine antigen
RO72676A2 (ro) * 1977-07-15 1982-08-17 Institutul "Dr.Ioan Cantacuzino",Ro Procedeu de determinare a continutului in anticorpi speci†ici antiamine biologic active a gamaglobulinelor
JPS5585526A (en) * 1978-12-23 1980-06-27 Nippon Zoki Pharmaceut Co Ltd Remedy for allergic disease
US4704273A (en) * 1982-05-17 1987-11-03 Mcmichael John Methods and materials for treatment of rheumatoid arthritis
US4705685A (en) * 1982-05-17 1987-11-10 Mcmichael John Methods and materials for treatment of disease states involving immunological factors
JPS58225027A (ja) * 1982-06-23 1983-12-27 Fujirebio Inc ヒスタミン加グロブリン製剤
US4705687A (en) 1985-06-17 1987-11-10 Ortho Pharmaceutical (Canada) Ltd. Treatment of autoimmune diseases such as rheumatoid arthritis with suppressor factor
US5112738A (en) 1985-07-03 1992-05-12 Miles Inc. Histamine derivatives, immunogen conjugates and antibodies raised thereto
US5244902A (en) 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
IT1237475B (it) 1989-10-06 1993-06-07 Allergeni modificati chimicamente e procedimento per la loro preparazione
US5192773A (en) 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
JP3193205B2 (ja) * 1993-08-09 2001-07-30 日本臓器製薬株式会社 好酸球増多抑制剤

Also Published As

Publication number Publication date
CN1108818C (zh) 2003-05-21
CN1148505A (zh) 1997-04-30
JPH0959180A (ja) 1997-03-04
AU713296B2 (en) 1999-11-25
US6627194B1 (en) 2003-09-30
EP0758656B1 (en) 2003-10-22
CA2183020A1 (en) 1997-02-12
DE69630423D1 (de) 2003-11-27
EP0758656A2 (en) 1997-02-19
AU6203396A (en) 1997-02-13
KR100436811B1 (ko) 2004-08-25
TW442495B (en) 2001-06-23
EP0758656A3 (en) 1997-08-06
DE69630423T2 (de) 2004-06-17
ATE252603T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
IT1288290B1 (it) Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
LU91079I2 (fr) Tramacet et ses dérivés pharmaceutiquement acceptables.
DE69233462D1 (de) Zusammensetzung die Tramadol und ein nichtsteroides entzündungshemmenden Mittel enthält
EA200100870A1 (ru) Композиции-ингибиторы циклооксигеназы-2 с быстро наступающим терапевтическим действием
ES2174970T3 (es) Mezcla propelente para formulacion de aerosol.
DK1586322T3 (da) Sammensætninger indeholdende thalidomid og dextamethason til behandling af cancer
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
WO1997049373A3 (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
LV11666A (lv) Farmaceitiskie preparati un medikamenti endotelialo traucejumu noversanai un arstesanai
RU2007104774A (ru) Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы
WO1999040883A3 (en) Compositions and methods for the treatment of cystic fibrosis
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
KR970009812A (ko) 활성화 면역글로불린
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
IL97796A0 (en) Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
ATE311904T1 (de) Halbfester verabreichungsträger und arzneimittel
RU94045866A (ru) Применение бисфенилалкилпиперазинов для лечения расстройств, вызванных злоупотреблением веществами, способ лечения
DE69813070D1 (de) Pharmazeutische Zubereitung zur oralen Anwendung enthaltend einen Histamin-Immunoglobulin Komplex
NO20021625L (no) Synergistiske kombinasjoner av en NK1 reseptor antagonist og en GABA strukturell analog
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
DE69124380T2 (de) Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee